Dr. Usman

Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) is a once-weekly dual GIP/GLP-1 receptor agonist that strongly suppresses appetite, slows stomach emptying and improves insulin … Read more

Tirzepatide (Mounjaro or Zepbound) works by slowing how quickly food leaves the stomach, increasing feelings of fullness and reducing overall appetite. These actions help control … Read more

Compounded tirzepatide is a custom-made version of the active ingredient found in branded Mounjaro and Zepbound, prepared by licensed compounding pharmacies. It is often used … Read more

Compounded tirzepatide is a custom-prepared version of the active ingredient found in branded Mounjaro and Zepbound. Pharmacies create it when patients need access during branded … Read more

Tirzepatide and semaglutide are both once-weekly injectable medications that belong to the incretin mimetic family and are used to treat type 2 diabetes and support … Read more

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for chronic weight management) is a once-weekly dual GIP/GLP-1 receptor agonist that produces substantial weight loss—often 15–22 % … Read more

Tirzepatide (Mounjaro or Zepbound) is injected subcutaneously once weekly to help manage type 2 diabetes or support chronic weight loss. The medication is delivered through … Read more

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for chronic weight management) is a once-weekly dual GIP/GLP-1 receptor agonist that delivers strong appetite suppression, slowed gastric … Read more

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for chronic weight management) is a once-weekly dual GIP/GLP-1 receptor agonist that lowers blood sugar, slows gastric emptying, … Read more

Tirzepatide is the active ingredient in Mounjaro (used mainly for type 2 diabetes) and Zepbound (approved for chronic weight management). It belongs to a newer … Read more